Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Hui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8164-1624; OpenAlex author ID A5004486459. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer. Last author DOI 10.3390/ph17121666↗
  2. Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic Cancer. Co-author DOI 10.1021/jacsau.1c00553↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingsheng Cheng · 2 shared papers, 2022–2024 · strength 0.44
  2. Jian Wang · 1 shared paper, 2024 · strength 0.28
  3. Yee Lin Tang · 1 shared paper, 2024 · strength 0.28
  4. Weihong Zhu · 1 shared paper, 2022 · strength 0.16
  5. Zhiqian Guo · 1 shared paper, 2022 · strength 0.16
  6. Dan Li · 1 shared paper, 2022 · strength 0.16
  7. Yining Tao · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.